Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy (Q78246228)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

R G Leenders

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

E W Damen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

E J Bijsterveld

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

H W Scheeren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

P H Houba

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

I H van der Meulen-Muileman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

E Boven

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

1597-1610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

The role of beta-glucuronidase in drug disposition and drug targeting in humans

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

Characterization of novel anthracycline prodrugs activated by human beta-glucuronidase for use in antibody-directed enzyme prodrug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-beta-glucuronidase conjugate in the specific treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

A novel connector linkage applicable in prodrug design

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

5-Fluorouracil derivatives with serum protein binding potencies

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

Diphenylphosphoryl azide. A new convenient reagent for a modified Curtus reaction and for the peptide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

N,N'-Disuccinimidyl Carbonate: A Useful Reagent for Alkoxycarbonylation of Amines

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

Adriamycin analogs. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

Improved characteristics of a human beta-glucuronidase-antibody conjugate after deglycosylation for use in antibody-directed enzyme prodrug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900095-4

7 January 2021

10.1016/S0968-0896(99)00095-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482452%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference